title: Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.
authors.affiliation: Department of Clinical Analysis and Immunology, UGC Clinical Laboratory, Institute of Biosanitary Research ibs.Granada, University of Granada Hospital Complex, Granada, Spain.
authors.forename: Natalia
authors.initials: N
authors.lastname: Aptsiauri
authors.affiliation: Tumor Immunology Laboratory, Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA.
authors.forename: Anahid
authors.initials: A
authors.lastname: Jewett
authors.affiliation: Agenus Inc., Lexington, MA, USA.
authors.forename: Arthur A
authors.initials: AA
authors.lastname: Hurwitz
authors.affiliation: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Shurin
authors.affiliation: Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. v.umansky@dkfz.de.|Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany. v.umansky@dkfz.de.
authors.forename: Viktor
authors.initials: V
authors.lastname: Umansky
mesh_terms: D000818:Animals; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D057285:Precision Medicine / Q000379:methods*
keywords: CITIM 2015; Cancer; Immunomonitoring; Immunosuppression; Immunotherapy; Tumor microenvironment